Doximity Inc (DOCS)
Return on equity (ROE)
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 147,582 | 137,632 | 123,144 | 118,841 | 112,818 | 118,876 | 141,055 | 150,844 | 154,783 | |||
Total stockholders’ equity | US$ in thousands | 901,397 | 864,614 | 871,467 | 990,787 | 966,116 | 930,174 | 878,964 | 902,166 | 878,594 | 838,848 | 772,560 | 728,452 |
ROE | 16.37% | 15.92% | 14.13% | 11.99% | 11.68% | 12.78% | 16.05% | 16.72% | 17.62% |
March 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $147,582K ÷ $901,397K
= 16.37%
Doximity Inc's return on equity (ROE) has shown fluctuations over the past several quarters, ranging from a low of 11.68% in the first quarter of 2023 to a high of 17.62% in the first quarter of 2022. The ROE for the most recent quarter, ending March 31, 2024, is 16.37%, indicating a solid performance in generating profits relative to shareholder equity. Overall, the trend in ROE appears to have been relatively stable and healthy, with occasional variations in performance. It is important for investors to continue monitoring ROE as a key indicator of the company's profitability and efficiency in utilizing shareholders' investments.
Peer comparison
Mar 31, 2024